Age (years): mean (SD) | 10.7±3.8 |
Male gender: n (%) | 43 (60.6) |
Race/ethnicity: n (%) | |
Non-Hispanic white | 39 (54.9) |
Hispanic | 23 (32.4) |
African-American | 6 (8.5) |
Other | 3 (4.2) |
BMI percentile: mean (SD) | 76.2±22.3 |
Obesity or overweight: n (%) | 34 (48.6) |
Glucose (mmol/L): mean (SD) | 21.8±10.2 |
HbA1c (%) (mmol/mol): mean (SD) | 12.1±2.2 (109±24) |
DKA: n (%) | 26 (38.8) |
Beta-hydroxybutyrate (mmol/L): mean (SD) | 5.3±4.3 |
Fasting C peptide (nmol/L): median (25th–75th centiles) | 0.143 (0.083–0.243) |
Expression of islet autoantibodies: n (%) | |
Insulin | 27 (38) |
GAD65 | 41 (57.8) |
ICA512/IA2 | 52 (73.2) |
ZnT8 | 44 (62) |
Number of islet autoantibodies expressed: n (%) | |
1 | 15 (21.1) |
2 | 25 (35.2) |
3 | 25 (35.2) |
4 | 6 (8.5) |
HLA DR3-DQ2/DR4-DQ8: n (%) | 16 (22.5) |
BMI, body mass index; DKA, diabetic ketoacidosis; GAD65, glutamic acid decarboxylase 65; HbA1c, glycated hemoglobin; HLA, human leukocyte antigen; ICA512/IA2, islet cell autoantigen 512; ZnT8, zinc transporter 8.